Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 6
1999 4
2001 2
2002 3
2003 5
2004 7
2005 9
2006 8
2007 9
2008 4
2009 6
2010 3
2011 5
2012 5
2013 8
2014 6
2015 10
2016 1
2017 5
2018 2
2019 2
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 28438054

105 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models.
Mathew L, Gaikwad A, Gonzalez A, Nugent EK, Smith JA. Mathew L, et al. Integr Cancer Ther. 2017 Sep;16(3):300-307. doi: 10.1177/1534735417704948. Epub 2017 Apr 25. Integr Cancer Ther. 2017. PMID: 28438054 Free PMC article.
Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I, Itoh T, Chen S. Kijima I, et al. J Steroid Biochem Mol Biol. 2005 Dec;97(4):360-8. doi: 10.1016/j.jsbmb.2005.09.003. Epub 2005 Nov 2. J Steroid Biochem Mol Biol. 2005. PMID: 16263272
Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.
Jelovac D, Macedo L, Goloubeva OG, Handratta V, Brodie AM. Jelovac D, et al. Cancer Res. 2005 Jun 15;65(12):5439-44. doi: 10.1158/0008-5472.CAN-04-2782. Cancer Res. 2005. PMID: 15958593 Free article.
The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens.
Brodie AH, Jelovac D, Long B. Brodie AH, et al. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):283-8. doi: 10.1016/s0960-0760(03)00368-6. J Steroid Biochem Mol Biol. 2003. PMID: 14623522
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.
Dowsett M, Pfister C, Johnston SR, Miles DW, Houston SJ, Verbeek JA, Gundacker H, Sioufi A, Smith IE. Dowsett M, et al. Clin Cancer Res. 1999 Sep;5(9):2338-43. Clin Cancer Res. 1999. PMID: 10499602 Free article. Clinical Trial.
The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ, Jelovac D, Thiantanawat A, Brodie AM. Long BJ, et al. Clin Cancer Res. 2002 Jul;8(7):2378-88. Clin Cancer Res. 2002. PMID: 12114443 Free article.
The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer.
Lu Q, Liu Y, Long BJ, Grigoryev D, Gimbel M, Brodie A. Lu Q, et al. Breast Cancer Res Treat. 1999 Sep;57(2):183-92. doi: 10.1023/a:1006225601046. Breast Cancer Res Treat. 1999. PMID: 10598045
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
Itoh T, Karlsberg K, Kijima I, Yuan YC, Smith D, Ye J, Chen S. Itoh T, et al. Mol Cancer Res. 2005 Apr;3(4):203-18. doi: 10.1158/1541-7786.MCR-04-0122. Mol Cancer Res. 2005. PMID: 15831674 Free article.
The effects of aromatase inhibitors and antiestrogens in the nude mouse model.
Lu Q, Yue W, Wang J, Liu Y, Long B, Brodie A. Lu Q, et al. Breast Cancer Res Treat. 1998 Jul;50(1):63-71. doi: 10.1023/a:1006004930930. Breast Cancer Res Treat. 1998. PMID: 9802621
L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice.
Mehta NR, Wurz GT, Burich RA, Greenberg BE, Griffey S, Gutierrez A, Bell KE, McCall JL, Wolf M, DeGregorio M. Mehta NR, et al. Clin Cancer Res. 2012 May 15;18(10):2861-71. doi: 10.1158/1078-0432.CCR-12-0168. Epub 2012 Mar 20. Clin Cancer Res. 2012. PMID: 22434666 Free article.
105 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page